Voucher Program Extended for Arthritis Drug

JANUARY 01, 2005

The Trial Script voucher program for Rheumatrex Dose Pack (methotrexate sodium tablets) has been extended to August 2005. Rheumatrex, manufactured by STADA Pharmaceuticals, Inc, is a once-weekly disease-modifying antirheumatic drug for rheumatoid arthritis.

In the voucher program, patients receive a free 1-month trial supply of Rheumatrex in any weekly dosage available (5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg). Physicians affix the voucher to the back of the prescription form. The patients activate the voucher by calling a toll-free number. Transactions are electronically processed through drug utilization programs, which may detect potential drug interactions.